Which Flu Shot Should You Get? The New mRNA Option

You walk into the pharmacy for a flu shot and the technician asks a question you did not expect: "Standard, high-dose, or the new mRNA one?" Behind the counter there is a laminated chart with five brand names on it. The line behind you is growing, and you have about ten seconds to decide.

That moment is more common this fall than ever. Deciding which flu shot you should get used to be simple, because most adults were offered one option. Now there are high-dose shots, an adjuvanted shot, a recombinant shot, a nasal spray you can take at home, and the first mRNA flu vaccine ever approved in the United States. Last winter's flu season started fast and hit hard, so the choice carries real weight.

This guide gives you a short answer by age, the actual trial numbers behind the new mRNA vaccine, and what to ask for at the counter so you are not guessing.

Why the Flu Shot Choice Matters More This Season

Last season hit hard. By early January, the CDC estimated at least 11 million flu illnesses, 120,000 hospitalizations, and 5,000 deaths, and classified the season as "moderately severe". At the same point the year before, the counts were roughly half that.

The main driver was a new branch of the H3N2 virus called subclade K. It made up about 90% of the H3N2 samples the CDC analyzed, and it was a weaker match for the strain in last year's shots. Even so, an interim CDC estimate found vaccinated people were about 35% less likely to need emergency or urgent care for flu.

This year's vaccine updates all three strains, including the H3N2 component. The type of shot you get still deserves a minute of thought. Flu activity in the U.S. usually builds through October and peaks between December and February, and your body needs about two weeks after the shot to build protection.

The Quick Answer by Age

If you only read one section, read this one. These recommendations come from the CDC's interim guidance for this season and the American Academy of Family Physicians flu guidance, which summarizes it for doctors.

• Children 6 months to 17 years: any vaccine licensed for their age. No product is preferred. Kids 6 months through 8 years who have never had a flu shot, or had only one dose before July 1, need two doses at least four weeks apart.
• Adults 18 to 49: any standard shot, the recombinant shot, or the FluMist nasal spray. No product is preferred.
• Adults 50 to 64: any age-appropriate shot, including the new mRNA vaccine. The mRNA option is available to you but carries no official preference.
• Adults 65 and older: ask for a high-dose, adjuvanted, or recombinant shot. The AAFP also lists mRNA as preferred for this group. If none of these is in stock, take whatever age-appropriate shot is available rather than leaving without one.
• Pregnant: an inactivated or recombinant shot, in any trimester. Not the nasal spray.

One old worry no longer applies. People with an egg allergy can receive any vaccine approved for their age.

The New mRNA Flu Vaccine, by the Numbers

Moderna's mFlusiva uses the same messenger RNA approach as the COVID vaccines. Instead of growing virus in chicken eggs for months, the vaccine gives your cells instructions to make a flu protein, and your immune system learns to recognize it. The practical upside is speed: mRNA doses can be made faster if the virus shifts mid-year.

The FDA gave full approval for adults 50 to 64. For people 65 and older it granted accelerated approval, based on a smaller study showing a strong immune response compared with an existing high-dose shot, and Moderna has to run a follow-up study in that age group, PBS NewsHour reported.

What the trial actually showed

The main trial enrolled roughly 40,000 adults aged 50 and older and compared mFlusiva with a standard-dose flu shot. It did not compare it with a placebo, so every number below is "better than the usual shot," not "better than nothing."

• Confirmed flu cases: 411 of 20,179 people in the mRNA group (2.0%) versus 557 of 20,124 in the standard group (2.8%).
• Relative efficacy: 26.6% fewer cases overall, and 27.4% fewer among people 65 and older.
• Serious adverse events: 2.2% versus 1.9%, which reviewers judged similar.
• Short-term side effects: sore arm, fever, headache, tiredness, and aches were more common with the mRNA shot.

A worked example: what 26.6% means for 1,000 people

Relative percentages can sound bigger than they are, so convert them to people. Take 1,000 adults over 50 through one flu season.

1. With the standard shot, the trial rate of 2.8% means about 28 people get confirmed flu.
2. With the mRNA shot, the 2.0% rate means about 20 people get it.
3. That is roughly 7 to 8 fewer cases per 1,000 people vaccinated, or one case avoided for about every 137 people who choose mRNA over standard.

For a healthy 55-year-old, that is a modest edge that comes with a higher chance of feeling rough for a day. For a 70-year-old with heart disease, where one flu case can mean a hospital stay, the same edge matters more. That is the real tradeoff to weigh, and it is a conversation worth having with your pharmacist or doctor.

Options for Adults 65 and Older

Older adults have the most choices and the most at stake. Immune response weakens with age, which is why standard shots are not the first pick after 65. Each preferred option tackles that problem differently:

• Fluzone High-Dose contains four times the antigen of a standard shot, giving a weaker immune system more to react to.
• Fluad adds an adjuvant, an ingredient that boosts the immune response to a normal amount of antigen.
• Flublok is a recombinant vaccine made without eggs or live virus, and it is licensed for anyone 18 and older.
• mFlusiva is the mRNA option, preferred by the AAFP for this group when available.

No official body ranks these four against each other for seniors. The best one is usually the one in stock today. Waiting two weeks for a specific brand leaves you unprotected during those two weeks.

Cost should not stop you. Medicare Part B covers one flu shot per season with no copay when the provider accepts Medicare, and that includes the preferred senior vaccines. If you are reviewing your coverage right now, our breakdown of Medicare open enrollment costs explains what else changed this year.

FluMist at Home: Who Can Skip the Needle

The nasal spray vaccine FluMist is back for another season, and it can now be ordered online and delivered to your door. A pharmacy or clinician reviews a screening questionnaire before shipping it.

The rules are specific. Adults 18 through 49 may give it to themselves. Children 2 through 17 may receive it from a parent or caregiver who is at least 18. Health care workers can still give it in person as before.

FluMist is a live, weakened vaccine, so it is off the table for several groups:

• Children under 2 and adults over 49.
• Anyone who is pregnant.
• Anyone with a weakened immune system.
• Anyone taking, or about to take, flu antiviral medicine, which would neutralize it.

For a parent with two needle-shy kids, the home option can turn a dreaded pharmacy trip into a two-minute kitchen-table task.

When to Get It and What to Do If You Still Get Sick

The best window for most people is September or October, but late is far better than never. Doctors keep vaccinating through the winter as long as flu is circulating, and peak season has not arrived yet. Adults 65 and older are generally advised not to go as early as July or August, because protection can fade before the winter peak.

No flu shot blocks every infection. If you get a fever, chills, and body aches that come on fast, call your doctor early. Antiviral drugs such as oseltamivir work best when started within 48 hours of the first symptoms, and doctors are told not to wait for a test result before treating high-risk patients.

Your daily habits shape how well the vaccine works too. Short sleep is linked to weaker vaccine responses, one more reason researchers now rank sleep ahead of diet and exercise for lifespan.

Frequently Asked Questions

Which flu shot is best for seniors?

Adults 65 and older should get a high-dose (Fluzone High-Dose), adjuvanted (Fluad), or recombinant (Flublok) shot. The American Academy of Family Physicians also lists the mRNA vaccine mFlusiva as preferred. No group ranks these against each other, so take whichever is available.

Is the mRNA flu vaccine better than the regular flu shot?

In a trial of about 40,000 adults over 50, it led to 26.6% fewer confirmed flu cases than a standard-dose shot. It also caused short-term side effects like sore arm and fever more often. It is approved only for adults 50 and older.

Is it too late to get a flu shot in November?

No. Flu season usually peaks between December and February, and protection takes about two weeks to build. Getting vaccinated in November or even December still covers you for the worst of the season.

Can I give myself the FluMist nasal spray at home?

Yes, if you are 18 to 49 and not pregnant or immunocompromised. You can order it online, and a pharmacy or clinician screens your answers before it ships. Parents can give it to children aged 2 to 17.

Ask for the Right Shot by Name

The flu shot decision now comes down to your age. Under 50, any approved shot or the nasal spray is a solid choice. From 50 to 64, the mRNA vaccine is a new option with a measured edge and a bit more next-day soreness. At 65 and older, ask for high-dose, adjuvanted, recombinant, or mRNA by name, and take whichever one the pharmacy has today.

Last winter showed how fast a mismatched strain can fill hospitals. This year's vaccine carries updated strains, and the window to use it is still open. Walk up to the counter knowing your answer before the technician asks the question.